AML-119 The Impact of Post-Remission Granulocyte Colony-Stimulating Factor (G-CSF) Use (G-CSFu) in the Phase 3 Studies of Venetoclax (Ven) Combination Treatments in Patients (Pts) With Newly Diagnosed Acute Myeloid Leukemia (AML)

Authors :: Courtney DiNardo
Keith Pratz
Panayiotis Panayiotidis
Xudong Wei
Vladimir Vorobyev
Àrpád Illés
Inho Kim
Vladimir Ivanov
Grace Ku
Catherine Miller
Meng Zhang
Fernando Tatsch
Jalaja Potluri
Xenia Schmidt
Christian Recher
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S214
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools